002082 Wanbangde Pharmaceutical Holding Group
- 7.08
- +0.42+6.31%
Wanbangde Pharmaceutical Holding Group News
Wanbangde Pharmaceutical Holding Group: Announcement of Annual Equity Distribution Implementation in 2023
Wanbangde Pharmaceutical Holding Group: Announcement on the implementation results of the company's actual controller's plan to increase the company's share holdings
Wanbangde Pharmaceutical Holding Group: Announcement on the progress of the company's actual controller's plan to increase the company's shares for more than half of the time
Wanbangde Pharmaceutical Holding Group: Northeast Securities 2023 Continued Supervision Opinions and Continued Supervision Summary Report on Wanbond's Issuance of Shares to Purchase Assets and Related Transactions
Wanbangde Pharmaceutical Holding Group: Announcement on the 2023 Profit Distribution Plan
Wan Bond: Announcement on the progress of implementation of the company\'s actual controller\'s plan to increase the company\'s share holdings
Wan Bond: Announcement on the actual controller of the company to increase the company\'s shares and subsequent plans to increase its holdings
Wan Bangde: Announcement on the release of the pledge of some shares of the actual controller
Wan Bangde: Announcement on the increase of company directors\' holdings in the company\'s shares
Wanbond: Announcement on the cancellation of the pledge and re-pledge of the actual controller\'s shares
Wanbond: Announcement on the cancellation of the pledge and re-pledge of the actual controller\'s shares
Wanbond: Prompt announcement on the issuance of shares to purchase assets and the listing and circulation of restricted shares through related transactions
Wanbond: The inspection opinion of Northeast Securities Co., Ltd. on the issuance of shares by Wanbond Pharmaceutical Holding Group Co., Ltd. to purchase assets and the listing and circulation of restricted shares through related transactions
Wan Bond: 2022 Annual Equity Distribution Implementation Notice
Wan Bond: Announcement on the progress of promised compensation for major asset restructuring performance and completion of share repurchases and cancellation
Wanbond: Northeast Securities\'s opinion on Wanbond\'s continued supervision of Wanbond\'s issuance of shares to purchase assets and related transactions in 2022
Wanbond: Northeast Securities's verification opinion on the fulfillment of Wanbond's 2022 performance promises and impairment tests for issuing shares to purchase assets and related transactions
Wanbond: Northeast Securities's Verification Opinion on Wanbond's 2022 Performance Compensation Plan for Issuing Shares to Purchase Assets and Related Transactions and Repurchase and Cancellation of Shares
Wan Bond: Announcement on the cancellation of the pledge of some of the shares of the actual controller
Wanbond: Announcement on the signing of the “Consun Securities Group Limited Share Transfer Intent Agreement” and the proposed planning of major asset restructuring
No Data